Genmab A (GMAB) Retained Earnings (2023 - 2025)

Genmab A's Retained Earnings history spans 3 years, with the latest figure at $4.1 billion for Q4 2025.

  • For Q4 2025, Retained Earnings rose 1913.27% year-over-year to $4.1 billion; the TTM value through Dec 2025 reached $4.1 billion, up 1913.27%, while the annual FY2025 figure was $4.1 billion, 1913.27% up from the prior year.
  • Retained Earnings reached $4.1 billion in Q4 2025 per GMAB's latest filing, up from -$226.0 million in the prior quarter.
  • In the past five years, Retained Earnings ranged from a high of $4.1 billion in Q4 2025 to a low of -$226.0 million in Q4 2024.
  • Average Retained Earnings over 3 years is $2.2 billion, with a median of $2.7 billion recorded in 2023.
  • Peak YoY movement for Retained Earnings: plummeted 108.26% in 2024, then surged 1913.27% in 2025.
  • A 3-year view of Retained Earnings shows it stood at $2.7 billion in 2023, then crashed by 108.26% to -$226.0 million in 2024, then soared by 1913.27% to $4.1 billion in 2025.
  • Per Business Quant, the three most recent readings for GMAB's Retained Earnings are $4.1 billion (Q4 2025), -$226.0 million (Q4 2024), and $2.7 billion (Q4 2023).